chr19-35351582-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005303.3(FFAR1):āc.31C>Gā(p.Leu11Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000461 in 1,541,122 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005303.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FFAR1 | NM_005303.3 | c.31C>G | p.Leu11Val | missense_variant | 2/2 | ENST00000246553.4 | NP_005294.1 | |
FFAR1 | XM_047438698.1 | c.31C>G | p.Leu11Val | missense_variant | 2/2 | XP_047294654.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FFAR1 | ENST00000246553.4 | c.31C>G | p.Leu11Val | missense_variant | 2/2 | NM_005303.3 | ENSP00000246553 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152258Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000703 AC: 10AN: 142168Hom.: 0 AF XY: 0.0000262 AC XY: 2AN XY: 76210
GnomAD4 exome AF: 0.0000238 AC: 33AN: 1388746Hom.: 0 Cov.: 31 AF XY: 0.0000175 AC XY: 12AN XY: 685408
GnomAD4 genome AF: 0.000249 AC: 38AN: 152376Hom.: 0 Cov.: 33 AF XY: 0.000268 AC XY: 20AN XY: 74522
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.31C>G (p.L11V) alteration is located in exon 1 (coding exon 1) of the FFAR1 gene. This alteration results from a C to G substitution at nucleotide position 31, causing the leucine (L) at amino acid position 11 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at